Noninvasive Assessment of Hepatic Steatosis

Slides:



Advertisements
Similar presentations
Abnormal Liver Tests and Fatty Liver on Ultrasound
Advertisements

Imaging in Intestinal Ischemic Disorders
Imaging of Ovarian Teratomas in Children: A 9-Year Review
When Should Abdominal Magnetic Resonance Imaging Be Used?
Thrombocytopenia With Abnormal Liver Function Tests
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice  Parambir.
Imaging Approach for Evaluation of Focal Liver Lesions
Flavia D. Mendes, Ayako Suzuki, Schuyler O. Sanderson, Keith D
Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.
Gastrointestinal and Hepatic Complications of Sickle Cell Disease
Millie D. Long, Bruce E. Sands 
Salma Akram, Darrell S. Pardi, John A. Schaffner, Thomas C. Smyrk 
Liver Masses: A Clinical, Radiologic, and Pathologic Perspective
Oren Shaked, Evan S. Siegelman, Kim Olthoff, K. Rajender Reddy 
Gastrointestinal Involvement in Polyarteritis Nodosa
Sarah E. Rowan, Marilyn E. Levi, Jean M
Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography
Staging of Pancreatic Adenocarcinoma by Imaging Studies
Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease  Kathleen E. Corey, Naga Chalasani  Clinical.
Todd H. Baron, MD, Thomas C. Smyrk, MD 
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Gastrointestinal and Hepatic Complications of Sickle Cell Disease
When Should Abdominal Magnetic Resonance Imaging Be Used?
Novel Computer-enhanced Visualization of Volumetric Laser Endomicroscopy Correlates Endoscopic and Pathological Images  Allon Kahn, Rish K. Pai, Norio.
Computerized Tomography Colonography: A Primer for Gastroenterologists
Prevalence and Mechanisms of Malnutrition in Patients With Advanced Liver Disease, and Nutrition Management Strategies  Kally Cheung, Samuel S. Lee, Maitreyi.
Carmel G. Cronin, Michael Moore, Michael A. Blake 
Diffuse Gastric Wall Thickening: Appearances Can Be Deceptive
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Joel G. Fletcher, James Huprich, Edward V. Loftus, David H
Evidence for Life Before Inflammatory Bowel Disease
Mariana Lazo, Irfan Zeb, Khurram Nasir, Russell P. Tracy, Matthew J
Judy A. Trieu, Mohammad Bilal, Ali Hashmi 
Maya Gambarin–Gelwan, Sanjiv V. Kinkhabwala, Thomas D
Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis  Zobair M. Younossi  Clinical.
Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay?  Brian J. McMahon, MD, Brenna C. Simons, PhD  Clinical.
Eighty-Year-Old Patient With History of a Twelve Millimeter Adenomatous Polyp Resected at Age of Seventy-Five Years  David Lieberman  Clinical Gastroenterology.
Activity-Based Costing and Management in a Hospital-Based GI Unit
Diagnostic Accuracy of Computed Tomography Using Lower Doses of Radiation for Patients With Crohn's Disease  Orla Craig, Siobhan O'Neill, Fiona O'Neill,
Bret J. Spier, Abdullah A. Fayyad, Michael R. Lucey, Eric A
Endoscopic Therapy for Barrett's Esophagus
Amie L. Harvey, Tommy Yen, Anand Kunda 
Abnormal Liver Tests and Fatty Liver on Ultrasound
Magnetic Resonance Imaging Findings in Patients With Pyrrolizidine Alkaloid–Induced Hepatic Sinusoidal Obstruction Syndrome  Xin Li, Xiaoqian Yang, Dong.
New Models of Gastroenterology Practice
Rashid N.S. Lui, MRCP, James Y.W. Lau, MD, FRCS 
Vikram A. Sahni, Koenraad J. Mortele 
Volume 150, Issue 3, Pages (March 2016)
Answer to Case of the Month #162
Volume 132, Issue 2, (February 2007)
A Young Woman With Gallstone Pancreatitis and Abnormal Liver Tests: When Is Endoscopic Retrograde Cholangiopancreatography Needed?  Andrew D. Rhim, Michael.
The Incidental Pancreatic Cyst on Abdominal Computerized Tomography Imaging: Diagnosis and Management  William R. Brugge  Clinical Gastroenterology and.
Refining Sample-Size Estimations Based Upon Placebo Response in Trials of Agents for Nonalcoholic Fatty Liver Disease  Veeral Ajmera, MD, MAS, Rohit Loomba,
Heritability of Nonalcoholic Fatty Liver Disease
Alan Bonder, MD, Nezam H. Afdhal, MD 
Renato Micelli Lupinacci, Manoel de Souza Rocha, Paulo Herman 
Hannah I. Awai, Kimberly P. Newton, Claude B
Autoimmune Liver Disease Associated With Celiac Disease in Childhood: A Multicenter Study  Silvia Caprai, Pietro Vajro, Alessandro Ventura, Marco Sciveres,
Hepatic Cyst? Clinical Gastroenterology and Hepatology
Multiple liver pseudotumors due to hepatic steatosis and fatty sparing: A non-invasive imaging approach  Andrea Delli pizzi, Domenico Mastrodicasa, Barbara.
Thrombocytopenia With Abnormal Liver Function Tests
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
An Assessment of the Severity of Interstitial Pancreatitis
Sun–Young Kim, Min–Geun Kim, Won–Choong Choi 
Coagulation in Liver Disease: A Guide for the Clinician
Trunk Fat as a Determinant of Liver Disease
Variation of Agreement in Polyp Size Measurement Between Computed Tomographic Colonography and Pathology Assessment: Clinical Implications  Samir Gupta,
Black and White Liver Clinical Gastroenterology and Hepatology
Medical Therapy for Refractory Pediatric Crohn’s Disease
Presentation transcript:

Noninvasive Assessment of Hepatic Steatosis Sameer M. Mazhar, Masoud Shiehmorteza, Claude B. Sirlin  Clinical Gastroenterology and Hepatology  Volume 7, Issue 2, Pages 135-140 (February 2009) DOI: 10.1016/j.cgh.2008.11.023 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Fat fraction maps of the liver at the same level with the conventional technique (A) and the novel spectrally modeled relaxation-invariant technique (B). Colocalized regions of interest are shown in the right lobe of the liver (circles). The conventional technique shows a fat fraction of 2.6% within the region of interest, which is considered nonpathologic. The novel technique shows 8.9% fat fraction in the region of interest, which meets criteria for pathologic fat deposition. Clinical Gastroenterology and Hepatology 2009 7, 135-140DOI: (10.1016/j.cgh.2008.11.023) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Transverse US image of the liver in a 45-year-old man with fatty liver disease. The liver is hyperechoic in the near field (top half of image). Because of beam attenuation, the liver becomes progressively hypoechoic in the far field (bottom half of image). Note that only a portion of the right hemidiaphragm (arrow) is visible. Beam attenuation obscures the remainder of the hemidiaphragm. In addition, there is a paucity of intrahepatic structures. The portal vein (PV) is visible in the porta hepatis, but its intrahepatic branches are not evident. The gallbladder (GB) is incidentally noted. Clinical Gastroenterology and Hepatology 2009 7, 135-140DOI: (10.1016/j.cgh.2008.11.023) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 Axial unenhanced CT scan through the liver in the same 45-year-old man in Figure 2. The liver is diffusely hypodense and has lower attenuation than the intrahepatic vessels, giving the appearance of a contrast-enhanced examination. The heart is incidentally noted. C, cava; arrows, hepatic veins. Clinical Gastroenterology and Hepatology 2009 7, 135-140DOI: (10.1016/j.cgh.2008.11.023) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 Out-of-phase (OP) and in-phase (IP) MR images of the liver in a 36-year-old woman with fatty liver disease. The liver loses signal intensity on the OP compared with the IP image, indicating the presence of fat and water within liver tissue voxels. A normal liver would have similar signal intensity on the OP and IP images. Clinical Gastroenterology and Hepatology 2009 7, 135-140DOI: (10.1016/j.cgh.2008.11.023) Copyright © 2009 AGA Institute Terms and Conditions

Figure 5 Spectrally modeled relaxation-invariant MR technique performed on a 53-year-old man with fatty liver disease. Source images (left panels) are obtained at serial out-of-phase and in-phase echo times. A low flip angle is used to reduce T1 effects. A synthetic fat fraction map (right) is generated from the source images by measuring and correcting for T2* and modeling fat-fat interference effects. Note that the intrahepatic blood vessels and spleen are dark on the fat fraction map because these structures are devoid of fat. Clinical Gastroenterology and Hepatology 2009 7, 135-140DOI: (10.1016/j.cgh.2008.11.023) Copyright © 2009 AGA Institute Terms and Conditions